Skip to main content Accessibility help
×
Home

Antigenicity in hamsters of inactivated vaccines prepared from recombinant influenza viruses

  • M. Hamzawi (a1), R. Jennings (a1) and C. W. Potter (a1)

Summary

Inactivated vaccines prepared from influenza virus strains obtained by the recombination of A/PR/8/34 (H1N1) or A/FM/1/47 (H1N1) viruses with A/Victoria/3/75 (H3N2) virus, were tested for their antigenicity in hamsters. The parental origin of the genes of each cloned recombinant virus was determined by polyacrylamide gel electrophoresis, and vaccines prepared from each strain by concentration, purification on sucrose density gradients and inactivation with formalin. All the recombinant strains used in these studies possessed surface haemagglutinin and neuraminidase antigens derived from the A/Victoria/75 parent strain.

On inoculation into hamsters, at equivalent concentrations, these vaccines varied in their ability to induce haemagglutination-inhibiting (HI) antibodies in the serum. This variation was not dependent on concentration and was observed using neutralization and single radial haemolysis, as well as HI. The possible reasons for the findings are discussed.

    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Antigenicity in hamsters of inactivated vaccines prepared from recombinant influenza viruses
      Available formats
      ×

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Antigenicity in hamsters of inactivated vaccines prepared from recombinant influenza viruses
      Available formats
      ×

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Antigenicity in hamsters of inactivated vaccines prepared from recombinant influenza viruses
      Available formats
      ×

Copyright

References

Hide All
Abou-Donia, H., Jennings, R. & Potter, C. W. (1980). Growth of influenza A viruses in hamsters. Archives of Virology 65, 99107.
Aymard-Henry, M., Coleman, M. T., Dowdle, W. R., Laver, W. G., Schild, G. C. & Webster, R. G. (1973). Influenza virus neuraminidase and neuraminidase-inhibition test procedures. Bulletin of the World Health Organisation 48, 199202.
Bachmayer, H. (1975). Selective solubilisation of haemagglutinin and neuraminidase from influenza viruses. Intervirology 5, 260272.
Baez, M., Palese, P. & Kilbourne, E. D. (1980). Gene composition of high-yielding influenza vaccine strains obtained by recombination. Journal of Infectious Diseases 141, 362365.
Brady, M. I. & Furminger, I. G. S. (1976). A surface antigen influenza vaccine. I. Purification of haemagglutinin and neuraminidase proteins. Journal of Hygiene 77, 161180.
Brand, C. & Palese, P. (1980). Sequential passage of influenza virus in embryonated eggs or tissue culture: Emergence of mutants. Virology 107, 424433.
Brand, C. M. & Skehel, J. J. (1972). Crystalline antigen from the influenza virus envelope. Nature New Biology 238, 145147.
Davenport, F. M. (1961). Inactivated influenza virus vaccine: past present and future. American Review of Respiratory Diseases (Supplement) 83, 146156.
Davenport, F. M. (1979). The search for the ideal influenza vaccine. Journal of Biological Standardisation 55, 7886.
Erickson, A. H. & Kilbourne, E. D. (1980). Mutation in the haemagglutinin of A/N–WS/33 influenza virus recombinants influencing sensitivity to trypsin and antigenic reactivity. Virology 107, 320330.
Expert Committee on Respiratory Virus Diseases (1959). World Health Organisation Technical Report Number 170. Geneva: World Health Organisation.
Fazekas de St Groth, S., Witchell, S. J. & Lafferty, K. J. (1958). An improved assay for neutralising antibodies against influenza viruses. Journal of Hygiene 56, 415426.
Fenton, R. J., Jennings, R. & Potter, C. W. (1977). The serological response of experimental animals to inactivated whole and split influenza virus vaccines. Journal of Biological Standardisation 5, 217229.
Florent, G., Lobman, M., Beare, A. S. & Zygraich, N. (1977). RNA's of influenza A recombinant viruses derived from parents of known virulence for man. Archives of Virology 54, 1928.
Jennings, R., Denton, M. D. & Potter, C. W. (1976). The hamster as an experimental animal for the study of influenza. Medical Microbiology and Immunology 162, 217226.
Jennings, R. & Potter, C. W. (1973). Enhanced response to influenza A vaccines in hamsters primed by prior heterotype influenza infection. Archiv. für die gesamte Virusforschung 42, 197206.
Jennings, R., Potter, C. W. & McLaren, C. (1974). Effect of preinfection and preimmunisation on the serum antibody response to subsequent immunisation with heterotypic influenza vaccines. Journal of Immunology 113, 18341843.
Kilbourne, E. D. (1963). Influenza vims genetics, Progress in Medical Virology 5, 79126.
Kilbourne, E. D. (1969). Future influenza vaccines and the use of genetic recombinants. Bulletin of the World Health Organisation 41, 643645.
Kilbourne, E. D. (1978). Genetic dimorphism in influenza viruses: Characteristics of stably associated haemagglutinin mutants differing in antigenicity and biological properties. Proceeding of the National Academy of Sciences U.S.A. 75, 62586262.
Laemmli, V. K. (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, London 227, 680685.
Laurell, C. B. (1965). Antigen-antibody crossed electrophoresis. Analytical Biochemistry 10, 358361.
Laver, W. G. & Webster, R. G. (1966). Influenza virus subunit vaccines: immunogenicity and lack of toxicity for rabbits of ether and detergent-disrupted virus. Journal of Immunology 96, 595605.
Lubeck, M. D., Palese, P. & Schulman, J. L. (1979). Nonrandom association of parental genes in influenza A virus recombinants. Virology 95, 269274.
McCahon, D. & Schild, G. C. (1972). Segregation of antigenic and biological characteristics during influenza virus recombination. Journal of General Virology 15, 7377.
McCahon, D., Stealey, V. & Beare, A. S. (1976). The production of live attenuated influenza A strains by recombination with A/Okuda/57 (H2N2). Postgraduate Medical Journal 52, 389394.
Oxford, J. S., Schild, G. C., Potter, C. W. & Jennings, R. (1979). The specificity of the anti-haemagglutinin antibody response induced in man by inactivated influenza vaccines and by natural infection. Journal of Hygiene 82, 5161.
Oxford, J. S., Schild, G. C., Wood, J. M., Newman, R. W. & Seagroatt, V. (1977). The assay of influenza virus structural antigens in vaccines by rocket immunoelectrophoresis. Developments in Biological Standardisation 39, 201208.
Potter, C. W. (1979). Prevention of influenza, in Virus Diseases (ed. Heath, R. B.), pp. 924. Pitman Medical.
Potter, C. W., Clark, A., Jennings, R., Schild, G. C., Wood, J. M. & McWilliams, P. K. A. (1980). Reactogenicity and immunogenicity of inactivated influenza A (H1N1) virus vaccine in unprimed children. Journal of Biological Standardisation 8, 3548.
Potter, C. W., Jennings, R., McLaren, C. & Clark, A. (1975). Immunity following intranasal administration of an inactivated, freeze-dried A/England/42/72 vaccine. Archives of Virology 48, 307316.
Reed, L. J. & Muench, H. (1938). A simple method for estimating 50% endpoints. American Journal of Hygiene 27, 493497.
Ritchey, M. B., Palese, P. & Schulman, J. L. (1977). Differences in protein patterns of influenza A viruses. Virology 76, 121128.
Schulman, J. L. & Kilbourne, E. D. (1971). Correlated studies of a recombinant influenza virus vaccine. II. Definition of antigenicity in experimental animals. Journal of Infectious Diseases 124, 463472.
Sever, J. L. (1962). Application of microtechnique to viral serological investigations. Journal of Immunology 88, 320329.
Schild, G. C., Oxford, J. S. & Virelizier, J. L. (1976). The immune response to influenza – methods of analysis for antibodies and antigens. In The Role of Immunological Factors in Infectious, Allergic and Autoimmune Processes (ed. Beers, R. F. and Bassett, E. G.). New York: Raven Press.
Schild, G. C., Wood, J. M. & Newman, R. W. (1975). A single-radial immunodiffusion technique for the assay of influenza haemagglutinin antigen. Bulletin of the World Health Organisation 52, 223231.
Unanue, E. R. (1972). The regulatory role of macrophages in antigenic stimulation. Advances in Immunology 15, 95165.

Antigenicity in hamsters of inactivated vaccines prepared from recombinant influenza viruses

  • M. Hamzawi (a1), R. Jennings (a1) and C. W. Potter (a1)

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed